No abstract available
Keywords:
IL-17; T cells; dendritic cells; gene expression; mild-to-moderate disease; psoriasis; secukinumab; type 17 T cells.
Publication types
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Double-Blind Method
-
Humans
-
Psoriasis* / drug therapy
-
Severity of Illness Index
-
Treatment Outcome
Substances
-
secukinumab
-
Antibodies, Monoclonal, Humanized